Good Medicine Podcast

This week on Good Medicine, Dr. David Bearss dives into the roles of the FDA and NIH in today’s healthcare landscape. He explores the vital impact these institutions have on innovation, safety, and public trust—while also examining the growing debates around how they operate. From differing perspectives across industry, academia, and government, Dave unpacks the complex views on what should evolve and why it matters.Whether you're in biotech, policy, or just curious about the forces shaping medicine, this episode offers a grounded, insightful look at two of the most influential organizations in health.SponsorsBioHive: ⁠https://www.biohive.comGalvan: https://www.galvan.healthFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePodTikTok: ⁠https://www.tiktok.com/@good.medicine.podcastLinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/

In this episode of Good Medicine, Dr. Bearss sits down with Dr. Ryan Watts, CEO of Denali Therapeutics, to explore the cutting edge of neurodegenerative disease research.They dive deep into the science behind treating Alzheimer’s, Parkinson’s, ALS, and other brain disorders — including how Denali is tackling one of the biggest challenges in medicine: getting therapies across the blood-brain barrier.Topics include:- Why the brain is uniquely hard to treat- How genetics and biomarkers are shaping drug development- Denali’s approach to targeted therapeutics and clinical trials- The future of neuroscience and precision medicineWhether you’re a scientist, student, investor, or just curious about how modern biotech is taking on brain disease, this is a conversation you don’t want to miss.Sponsors BioHive: ⁠https://www.biohive.com/⁠ Galvan: https://www.galvan.health/ Follow Good Medicine Podcast Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this solo episode, Dr. Bearss breaks down the controversial “Most Favored Nation” (MFN) drug pricing rule introduced during the Trump administration. What is the policy aiming to solve? How would it change the cost of prescription drugs in the U.S.? And why did it stir such intense debate across the healthcare and pharmaceutical industries?With clear, research-backed insight, David explores the economic and political implications of MFN, how it compares to international drug pricing models, and what it tells us about the future of healthcare reform in America.Whether you’re in healthcare, policy, or just trying to make sense of why your prescriptions cost so much, this is a must-listen.Sponsors BioHive: ⁠https://www.biohive.com/⁠ Galvan: https://www.galvan.health/ Follow Good Medicine Podcast Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/⁠

Dr. Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals and bioengineering PhD holder, shares his journey from research to revolutionizing drug discovery. He discusses the exciting intersection of AI and biology, emphasizing how machine learning can transform healthcare. The conversation also covers the integration of advanced tech in clinical trials and the need for healthcare to shift from treatment to prevention. With insights into data-driven innovation, it paints an optimistic picture for the future of medicine.

In this special episode of the Good Medicine Podcast, Kelvyn Cullimore sits down with Dr. David Bearss for a wide-ranging conversation that gives listeners a chance to get to know the voice behind the mic.From his early life and scientific journey to what motivates his work today, Dr. Bearss opens up about his path, passions, and perspective on the future of healthcare and innovation.🎧 Tune in to hear the story behind the scientist — and the heart behind the mission.Sponsors BioHive: ⁠https://www.biohive.com/⁠ Galvan: https://www.galvan.health/ Follow Good Medicine Podcast Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn:⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

On this episode of the Good MedicinePodcast, we discuss why drugs are so expensive. We break down the complex world of drug pricing—from research and development costs to patent protections, insurance dynamics, and the roles of pharmaceutical companies and middlemen.Whether you’re a curious patient, healthcare professional, or just wondering why your prescriptions keep getting more expensive, this episode will help you understand the real reasons behind rising drug prices—and what could be done to fix it.Sponsors BioHive: https://www.biohive.com/ Galvan: https://www.galvan.health/ Follow Good Medicine Podcast Insta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Dr. Joshua Schiffman is a pediatric hematologist-oncologist and Professor of Pediatrics and Investigator at Huntsman Cancer Institute at the University of Utah. Dr. Schiffman is passionate about introducing new medicines for patients with cancer and inflammatory diseases. Sponsors BioHive: https://www.biohive.com/ Galvan: https: https://www.galvan.health/Follow Good Medicine Podcast Insta: https://www.instagram.com/good.medicine.podcast/X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcastLinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/Dr. Joshua Schiffman PEEL Therapeutics: https://peeltx.com/ Li-Fraumeni syndrome: https://www.lfsassociation.org/what-is-lfs/

Dr. David Bearss welcomes you to the podcast with a short introduction.